Search - tctmd.com

Displaying 1 - 20 of 41

Sort: Relevancy | Date

News Daily News

AHA Selects 2023’s Leading Cardiovascular Research

Todd Neale

December 22, 2023

News Daily News

Who Benefits Most From Semaglutide and How Long Will That Take?

Shelley Wood

December 19, 2023

News Daily News

Oral GLP-1 Drug Danuglipron to Move Forward, but With Tweaks to Dose

L.A. McKeown

December 01, 2023

News Daily News

‘Smoldering Epidemic’ of CVD Risk Factors in Middle-Aged Adults

Michael O'Riordan

November 21, 2023

News Daily News

Mortality Risk Varies Among Patients With Very High LDL Levels

Michael O'Riordan

November 17, 2023

News Conference News AHA 2023

New CVD Risk Tool Can Spur Even Earlier Talk About Prevention

Yael L. Maxwell

November 14, 2023

Presentation AHA 2023

Population Health and Obesity: Achieving Equity and Feasibility

Presenter: Tiffany M. Powell-Wiley

November 11, 2023

News Daily News

Diabetes in Middle Age Linked to Earlier CVD Risk: Danish Study

L.A. McKeown

October 10, 2023

News Daily News

Major GI Events Rare but Real in Weight-Loss Patients on GLP-1 Drugs

Caitlin E. Cox

October 06, 2023

News Daily News

PET-Guided Strategy Lowers Risk, Boosts Outcomes in Stable CAD: CENTURY

Michael O'Riordan

September 29, 2023

News Daily News

European Regulators Investigating CV Safety of Weight-Loss Drug Mysimba

Michael O'Riordan

September 15, 2023

News Daily News

Mortality, CVD Benefits Seen at Relatively Low Daily Step Counts

Michael O'Riordan

September 08, 2023

News Conference News ESC 2023

STEP-HFpEF: Semaglutide Cuts Weight and Symptoms, Boosts Function

Shelley Wood

August 25, 2023

News Daily News

A Mix of Aerobic and Strength Exercise Is Best for Boosting Survival

Caitlin E. Cox

August 09, 2023

News Daily News

SELECT: Semaglutide Cuts CV Events in Adults With Overweight or Obesity

Todd Neale

August 08, 2023

News Daily News

Vegetarian Diets May Curb Cardiometabolic Risk: Meta-analysis

Caitlin E. Cox

August 01, 2023

News Daily News

CVD Risk Reduction With Exercise Also Seen in ‘Weekend Warriors’

Michael O'Riordan

July 24, 2023

News Daily News

New Chronic Heart Disease Guidelines Update Roles of GDMT, Imaging, and Revascularization

Michael O'Riordan

July 20, 2023

News Daily News

EMA Investigating Suicidal Thinking With GLP-1 Drugs for Weight Loss

Michael O'Riordan

July 12, 2023

News Daily News

Two New Studies Highlight Lack of Diversity in Cardiovascular RCTs

Michael O'Riordan

July 11, 2023

Advertisement

AHA Selects 2023’s Leading Cardiovascular Research

Who Benefits Most From Semaglutide and How Long Will That Take?

Oral GLP-1 Drug Danuglipron to Move Forward, but With Tweaks to Dose

‘Smoldering Epidemic’ of CVD Risk Factors in Middle-Aged Adults

Mortality Risk Varies Among Patients With Very High LDL Levels

New CVD Risk Tool Can Spur Even Earlier Talk About Prevention

Population Health and Obesity: Achieving Equity and Feasibility

Diabetes in Middle Age Linked to Earlier CVD Risk: Danish Study

Major GI Events Rare but Real in Weight-Loss Patients on GLP-1 Drugs

PET-Guided Strategy Lowers Risk, Boosts Outcomes in Stable CAD: CENTURY

European Regulators Investigating CV Safety of Weight-Loss Drug Mysimba

Mortality, CVD Benefits Seen at Relatively Low Daily Step Counts

STEP-HFpEF: Semaglutide Cuts Weight and Symptoms, Boosts Function

A Mix of Aerobic and Strength Exercise Is Best for Boosting Survival

SELECT: Semaglutide Cuts CV Events in Adults With Overweight or Obesity

Vegetarian Diets May Curb Cardiometabolic Risk: Meta-analysis

CVD Risk Reduction With Exercise Also Seen in ‘Weekend Warriors’

New Chronic Heart Disease Guidelines Update Roles of GDMT, Imaging, and Revascularization

EMA Investigating Suicidal Thinking With GLP-1 Drugs for Weight Loss

Two New Studies Highlight Lack of Diversity in Cardiovascular RCTs

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content